Farmakologiczna modulacja funkcji i żywotności astrocytów jako nowa strategia neuroprotekcji po niedokrwieniu

• Authors: Kinga Szydłowska , Bożena Kamińska

Title variants

EN

Pharmacological modulation of function and viability of astrocytes as a novel neuroprotective strategy in stroke

• Languages of publication: PL EN

Abstracts

EN

Neuron-astrocyte interactions are critical for signalling, energy metabolism, extracellular ion and glutamate homeostasis, volume regulation and neuroprotection in the central nervous system. Glutamate uptake by astrocytes may prevent excitotoxic glutamate elevation and determine neuronal survival. However, activation of astrogliosis and brain inflammation during cerebral ischemia exacerbates primary brain damage, resulting in upregulation of cytotoxic/infammatory cytokines and mediators, that alter blood flow and increase vascular permeability, thus leading to secondary damage and accumulation of immune cells in the brain. Although, astrocytes are more resistant than neurons to ischemic injury, astrocyte death have been demonstrated in animal models of brain ischemia. Exposure of cultured cortical astrocytes to glutamate induces apoptotic cell death and similar events can be detected in ischemic brain. FK506, an inhibitor of calcineurin and immunosuppressive drug, is neuroprotective in animal models of neurologic diseases, including focal and global ischemia. FK506 exerts a complex action on many processes ongoing in pathological brain: it directly protects neurons from glutamate-induced neuronal cell death, reduces gliosis and brain inflammation in animal models of stroke, and inhibits Glu-induced apoptosis of astrocytes in vitro and in ischemic brain. Altogether, recent findings suggest that modulation of astrocyte functions and astrocytic survival/cell death in neurodegeneration may be a novel therapeutic strategy in neurological disorders.

• Journal: Kosmos
• Year: 2008
• Volume: 57
• Issue: 3-4
• Pages: 315-329

Dates

published

2008

Contributors

author

Kinga Szydłowska

• Pracownia Regulacji Transkrypcji, Instytut Biologii Doświadczalnej im. M. Nenckiego PAN, Pasteura 3, 02-093 Warszawa, Polska

author

Bożena Kamińska

• Pracownia Regulacji Transkrypcji, Instytut Biologii Doświadczalnej im. M. Nenckiego PAN, Pasteura 3, 02-093 Warszawa, Polska

References

• Amin N., Pearce B. 1997. Glutamate toxicity in neuron-enriched and neuron-astrocyte co-cultures: effect of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylate. Neurochem. Int. 30, 271-276.
• Arii T., Kamiya T., Arii K., Ueda M., Nito C., Katsura K. I., Katayama Y., 2001. Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat: therapeutic time window for FK506 transient focal ischemia. Neurol. Res. 23, 755-760.
• Arundine M., Tymianski M., 2003. Molecular mechanism of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34, 325-337
• Bejot Y., Caillier M., Ben Salem D., Couvreur G., Rouaud O., Osseby G. v., Durier J., Marie C., Moreau T., Giroud M., 2008. Ischemic stroke subtypes and associated risk factors: a French population-based study. J. Neurol. Neurosurg. Psychiatry. DOI: 10.1136/jnnp.2008.150318.
• Benveniste E. N., 1998. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev. 9, 259-275.
• Bezprozvanny I., Mattson M. P., 2008. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci. 31, 454-63.
• Bezzi, P., Volterra, A., 2001. A neuron-glia signalling network in the active brain. Cur. Opin. Neurobiol., 11, 387-394.
• Bochelen D., Rudin M., Sauter A., 1999. Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. J. Pharmacol. Exp. Ther. 288, 653-659.
• Bolanos J. P., Almeida A., 1999. Roles of nitric oxide in brain hypoxia-ischemia. Biochim. Biophys. Acta 1411, 415-436.
• Brecht S., Schwarze K., Waetzig V., Christner C., Heiland S., Fischer G., Sartor K., Herdegen T., 2003. Changes in peptidyl-prolyl cisl trans isomerase activity and FK506 binding protein expression following neuroprotection by FK506 in the ischemic rat brain. Neuroscience 120, 1037-1048.
• Brown D. R., 1999. Neurons depend on astrocytes in a coculture system for protection from glutamate toxicity. Mol. Cell. Neurosci. 13, 379-389.
• Brown D. R., 2000. Neuronal release of Vasoactive Intestinal Peptide is important to astrocytic protection of neurons from glutamate toxicity. Mol. Cell. Neurosci. 15, 465-475.
• Bullock R., Zauner A., Woodward J., Young H. F., 1995. Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke 26, 2187-2189.
• Butcher S. P., Henshall D. C., Teramura Y., Iwasaki K., Sharkey J., 1997. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an anti-excitotoxic mechanism. J. Neurosci. 17, 6939-6946.
• Castillo J., Davalos A., Naveiro J., Noya M., 1996. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 27, 1060-1065.
• Chen Ch.-J., Liao S.-l., Kuo J.-S., 2000. Gliotoxic action of glutamate on cultured astrocytes. J. Neurochem. 75, 1557-1565.
• Chen Y., Swanson R. A., 2003. Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 23, 137-149.
• Ciccarelli R., D'alimonte I., Ballerini P., D'auro M., Nargi E., Buccella S., Di Iorio P., Bruno V., Nicoletti F., Caciagli F., 2007. Molecular signalling mediating the protective effect of A1 adenosine and mGlu3 metabotropic glutamate receptor activation against apoptosis by oxygen/glucose dePrivation in cultured astrocytes. Mol. Pharmacol. 71, 1369-80.
• Clipstone N. A., Crabtree G. R., 1992. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357, 695-697.
• Dalkara T., Yoshida T., Irikura K., Moskowitz M. A., 1994. Dual role of nitric oxide in focal cerebral ischemia. Neuropharmacology 33, 1447-1452.
• Davalos A., Castillo J., Noya M., 1997. Duration of glutamate release after acute ischemic stroke. Stroke 28, 708-710.
• Dirnagl U., Iadecola C., Moskowitz M. A., 1999. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397.
• Dirnagl U., Priller J., 2005. Focal cerebral ischemia: the multifaceted role of glial cells. 'Neuroglia', Wydanie drugie, Oxford University Press
• Dugan L. L., Bruno V. M. G., Amagasu S. M., Giffard R. G., 1995. Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J. Neurosci. 15, 4545-4555.
• Dugan L. L., Kim-Han J. S., 2004. Astrocyte mitochondria in in vitro models of ischemia. J. Bioenerg. Biomembr. 36, 317-321.
• Endoh M., Maiese K., Wagner J., 1994. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res. 651, 92-100.
• Erecinska M., Siver I. A., 1990. Metabolism and role of glutamate in mammalian brain. Prog. Neurobiol. 35, 245-296.
• Feustel P. J., Jin Y., Kimelberg H. K., 2004. Volume-regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra. Stroke 35, 1164-1168.
• Friberg H., Ferrand-drake M., Bengtsson F., Halestrap A. P., Wieloch T., 1998. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J. Neurosci. 18, 5151-5159.
• Furuichi Y., Katsuta K., Maeda M., Ueyama N., Moriguchi A., Matsuoka N., Goto T., Yanagihara T., 2003. Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacy. Brain Res. 965, 137-145.
• Giffard R. G., Swanson R. A., 2005. Ischemia-induced programmed cell death in astrocytes. Glia 50, 299-306.
• Gold B. G., Densmore V., Shou W., Matzuk M. M., Gordon H. S., 1999. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J. Pharmacol. Exp. Ther. 289, 1202-1210.
• Guo X., Dillman J. F. 3rd, Dawson V. L., Dawson T. M., 2001. Neuroimmunophilins: novel neuroprotective and neuroregenerative targets. Ann. Neurol. 50, 6-16.
• Guthrie P. B., Knappenberger J., Segal M., Bennett M. V., Charles A. C., Kater S. B., 1999. ATP released from astrocytes mediates glial calcium waves. J. Neurosci. 19, 520-528.
• Han B. C., Koh S. B., Lee E. Y., Seong Y. H., 2004. Regional difference of glutamate-induced swelling in cultured rat brain astrocytes. Life Sci. 76, 573-583.
• Hassel B., Boldingh K. A., Narvesen C., Iversen E. G., Skrede K. K., 2003. Glutamate transport, glutamine synthetase and phosphate-activated glutaminase in rat CNS white matter. A quantitative study. J. Neurochem. 87, 230-237.
• Hassinger T. D., Guthrie P. B., Atkinson P. B., Bennett M. V., Kater S. B., 1996. An extracellular signaling component in propagation of astrocytic calcium waves. Proc. Natl. Acad. Sci. USA, 93, 13268-13273.
• Hertz L., Zielke R., 2004. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci. 27, 735-743.
• Huang Z., Huang P. L., Panahian N., Dalkara T., Fishman M. C., Moskowitz M. A., 1994. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265, 1883-1885.
• Jabaudon D., Scanziani M., Gahweiler B. H., Gerber U., 2000. Acute decrease in net glutamate uptake during energy dePrivation. Proc. Natl. Acad. Sci. USA 97, 5610-5615.
• Jacobson J., Duchen M. R., 2002. Mitochondrial oxidative stress and cell death in astrocytes - requirement for stored Ca2+ and sustained opening of the permeability transition pore. J. Cell Sci. 115, 1175-1188.
• Kamińska B., Zawadzka M., 2003. Molekularny mechanizm neuroprotekcyjnego działania immunosupresantów - fakty i hipotezy. Neuroprotekcja (XX Zimowa Szkoła Instytutu Farmakologii PAN Mogilany), 41-49.
• Kaminska B, Gaweda-walerych K, Zawadzka M., 2004. Molecular mechanisms of neuroprotective action of immunosuppressants--facts and hypotheses. J. Cell. Mol. Med. 8, 45-58.
• Kawahara K., Hosoya R., Sato H., Tanaka M., Nakajima T., Iwabuchi S., 2002. Selective blocade of astrocytic glutamate transporter GLT-1 with dihydrokainate prevents neuronal death during oubain treatment of astrocyte/neuron cocultures. Glia 40, 337-349.
• Keswani S. C., Chander B., Hasan C., Griffin J. W., Mcarthur J. C., Hoke A., 2003. FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. Ann. Neurol. 53, 57-64.
• Kiedrowski L., Brooker G., Costa E., Wroblewski J. T., 1994. Glutamate impairs neuronal calcium extrusion while reducing sodium gradient. Neuron 12, 295-300.
• Kino T., Hatanaka H., Hashimoto M., Nishiyama M., Goto T., Okuhara M., Kohsaka M., Aoki H., Imanaka H., 1987. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J. Antibiot. (Tokyo) 40, 1249-1255.
• Kosugi T., Kawahara K., 2006. Reversed actrocytic GLT-1 during ischemia is crucial to excitotoxic death of neurons, but contributes to the survival of astrocytes themselves. Neurochem. Res. 31, 933-943.
• Labiche L. A., Grotta J. C., 2004. Clinical trials for cytoprotection in stroke. NeuroRx. 1, 46-70.
• Labrande C., Velly L., Canolle B., Guillet B., Masmejean F., Nieoullon A., Pisano P., 2006. Neuroprotective effects of Tacrolimus (FK506) in a model of ischemic cortical cell cultures: role of glutamate uptake and FK506 binding protein 12 kDa. Neuroscience 137, 231-239.
• Lai M. M., Hong J. J., Ruggiero A. M., Burnett P. E., Slepnev V. I., De Camilli P., Snyder S. H., 1999. The calcineurin-dynamin 1 complex as a calcium sensor for synaptic vesicle endocytosis. J. Biol. Chem. 274, 25963-25966.
• Leist M., Nicotera P., 1998. Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res. 239, 183-201.
• Liu D., Smith C. L., Barone F. C., Ellison J. A., Lysko P. G., Li K., Simpson I. A., 1999. Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain. Brain. Res. Mol. Brain. Res. 68, 29-41.
• Madsen J. R., Macdonald P., Irwin N., Goldberg D. E., Yao G. L., Meiri K. F., Rimm I. J., Stieg P. E., Benowitz L. I., 1998. Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp. Neurol. 154, 673-683.
• Maeda M., Furuichi Y., Ueyama N., Moriguchi A., Satoh N., Matsuoka N., Goto T., Yanagihara T., 2002. A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window. J. Cereb. Blood Flow Metab. 22, 1205-1211.
• Mitani A., Tanaka K. 2003. Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J. Neurosci. 23, 7176-7182.
• Mori T., Tateishi N., Kagamiishi Y., Shimoda T., Satoh S., Ono S., Katsube N., Asano T., 2004. Attenuation of a delayed increase in the extracellular glutamate level in the peri-infarct area following focal cerebral ischemia by a novel agent ONO-2506. Neurochem. Int. 45, 381-387.
• Morioka T., Kalehua A. N., Streit W. J., 1993. Characterization of microglial reaction after middle cerebral artery occlusion in rat brain. J. Comp. Neurol. 327, 23-32.
• Nottingham S., Knap P. P, Springer J., 2002. FK506 treatment inhibits caspase-3 activation and promotes oligodendroglial survival following traumatic spinal cord injury. Exp. Neurol. 177, 242-251.
• Panickar K. S., Norenberg M. D., 2005. Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia 50, 287-298.
• Perez-Capote K., Serratosa J., Sola C., 2004. Glial activation modulates glutamate neurotoxicity in cerebellar granule cell cultures. Glia 45, 258-268.
• Phillis J. W., Ren J., O'regan M. H., 2000. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DL-threo-beta-benzyloxyaspartate. Brain Res. 880, 224.
• Pinheiro P. S., Mulle C., 2008. Presynaptic glutamate receptors: physiological functions and mechanisms of action. Nat. Rev. Neurosci. 9, 423-436.
• Pitt D., Nagelmeier I. E., Wilson H. C., Raine C. S., 2003. Glutamate uptake by oligodendrocytes - Implications for excitotoxicity in multiple sclerosis. Neurology 61, 1113-1120.
• Planas A., Chamorro A., 2006. Inflammation in stroke. IJNN 2, 110-119.
• Poulter M. O., Payne K. B., Steiner J. P., 2004. Neuroimmunophilins: a novel drug therapy for the reversal of neurodegenerative disease? Neuroscience 128, 1-6.
• Privat. A., 2003. Astrocytes as support for axonal regeneration in the central nervous system of mammals. Glia 43, 91-103.
• Pyrzynska B., Lis A., Mosieniak G., Kaminska B., 2001. Cyclosporin A-sensitive signalling pathway involving calcineurin regulates survival of reactive astrocytes. Neurochem. Int. 38, 409-415.
• Rao V. L., Dogan A., Todd K. G., Bowen K. K., Kim B. T., Rothstein J. D., Dempsey R. J., 2001. Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain. J. Neurosci. 21, 1876-1883.
• Reichert S. A., Kim-Han J. S., Dugan L. L., 2001. The mitochondrial permeability transition pore and nitric oxide synthase mediate early mitochondrial depolarization in astrocytes during oxygen-glucose deprivation. J. Neurosci. 21, 6608-6616.
• Ridet J. L., Malhotra S. K., Privat A., Gage F. H., 1997. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 20,570-577.
• Rosenberg P. A., Amin S., Leitner M., 1992. Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture. J. Neurosci. 12, 56-61.
• Rossi D. J., Brady J. D., Mohr C., 2007. Astrocyte metabolism and signaling during brain ischemia. Nat. Neurosci. 10, 1377-1386.
• Roze E., Saudou F., Caboche J., 2008. Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments. Curr. Opin. Neurol. 24, 497-503.
• Salińska E., Danysz W., Łazarewicz J. W., 2005. The role of excitotoxicity in neurodegeneration. Folia Neuropathol. 43, 322-339.
• Schousboe A., Divac I., 1979. Differences in glutamate uptake in astrocytes cultured from different brain regions. Brain Res.177, 407-409.
• Seki Y., Feustel P.,j., Keller R. w. Jr., Tranmer B. I., Kimelberg H. K., 1999. Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker. Stroke. 30, 433-440.
• Sharkey J., Butcher S. P., 1994. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature 371, 336-339.
• Sihra T. S., Naim A. C., Kloppenburg P., Lin Z., Pouzat C., 1995. A role for calcineurin (protein phosphatase-2B) in the regulation of glutamate release. Bioch. Biophys. Res. Com. 212, 609-616.
• Singleton R. H., Stone J. R., Okonkwo D. O., Pellicane A. J., Povlishock J. T., 2001. The immunophilin ligand FK506 attenuates axonal injury in an impact-acceleration model of traumatic brain injury. J. Neurotrauma 18, 607-614.
• Slusher B. S., Vornov J. J., Thomas A. G., Hurn P. D., Harukuni I., Bhardwaj A., Traystman R. J., Robinson M. B., Britton P., May Lu X.-c., Tortella F. C., Wozniak K. M., Yudkoff M., Potter B. M., Jackson P. F., 1999. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nature Med. 5, 1396-1402.
• Sonnewald U., Qu H., Aschner M., 2002. Pharmacology and toxicology of astrocyte-neuron glutamate transport and cycling. J. Pharmacol. Exp. Ther. 301, 1-6.
• Spillson A. B., Russel J. W., 2003. Metabotropic glutamate receptor regulation of neuronal cell death. Exp. Neurol. 18, S97-S105.
• Stys P. K., Waxman S. G., Ransom B. R., 1991. Na(+)-Ca2+ exchanger mediates Ca2+ influx during anoxia in mammalian central nervous system white matter. Ann. Neurol. 30, 375-380.
• Stys P. K., Waxman S. G., Ransom B. R., 1992. Ionic mechanisms of anoxic injury in mammalian CNS whie matter: role of Na+ channels and Na(+)-Ca2+ exchanger. J. Neurosci. 12, 430-439.
• Swanson R. A., 2005. Astrocyte neurotransmitter uptake. 'Neuroglia' Wydanie drugie, Oxford University Press
• Swanson R. A., Ying W., Kauppinen T. M., 2004. Astrocyte influences on ischemic neuronal death.Curr. Mol. Med. 4, 193-205.
• Syntichaki P., Tavernarakis N., 2003. The biochemistry of neuronal necrosis: rouge biology? Nature Neurosci. 4, 67-684.
• Szydlowska K., Zawadzka M., Kaminska B., 2006. Neuroprotectant FK506 inhibits glutamate-induced apoptosis of astrocytes in vitro and in vivo. J. Neurochem. 99, 965-975.
• Tabernero A., Medina J. M, Giaume C., 2006. Glucose metabolism and proliferation in glia: role of astrocytic gap junctions. J. Neurochem. 9 9, 1049-1061.
• Takamatsu H., Tsukada H., Noda A., Kakiuchi T., Nishiyama S., Nishimura S., Umemura K., 2001. FK506 attenuates early ischemic neuronal death in a monkey model of stroke. J. Nucl. Med. 42, 1833-1840.
• Takuma K., Baba A., Matsuda T., 2004. Astrocyte apoptosis: implications for neuroprotection. Prog. Neurobiol. 72, 111-127.
• Tokime T., nozaki k., kikuchi h., 1996. Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil. Neurosci. Lett. 206, 81-84.
• Vanlangenakker N., Berghe T.v., Krysko D.v., Festjens N., Vandenabeele P., 2008. Molecular mechanisms and pathophysiology of necrotic cell death. Curr. Mol. Med. 8, 207-220.
• Waldmeier P. C., Feldtrauer J. J., Qian T., Lemasters J. J., 2002. Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. Mol. Pharmacol. 62, 22-29.
• Wilhelmsson U., Bushong E. A., Price D. L., Smarr B. L., Phung V., Terada M., Ellisman M. H., Pekny M., 2006. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc. Natl. Acad. Sci. USA 103, 17513-17518.
• Woloshin S., Schwartz L. M., Welch H. G., 2008. The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J. Natl. Cancer Inst. 100, 845-853.
• Yu S. P., Choi D. W., 1997. Na(+)-Ca2+ exchange currents in cortical neurons: concominant forward and reverse operation and effect of glutamate. Eur. J. Neurosci. 9, 1273-1281.
• Yuan H., Zheng J. C., Liu P., Zhang S. F., Xu J. Y., Bai L. M., 2007. Pathogenesis of Parkinson's disease: oxidative stress, environmental impact factors and inflammatory processes. Neurosci. Bull. 23, 125-130.
• Zagami C. J., Beart P. M., Wallis N., Nagley P., O'shea R. D., 2008. Oxidative and excitotoxic insults exert differential effects on spinal motoneurons and astrocytic glutamate transporters: Implications for the role of astrogliosis in amyotrophic lateral sclerosis. Glia. DOI: 10.1002/glia.20739.
• Zawadzka M., Kaminska B., 2003. Immunosuppressant FK506 affects multiple signalling pathways and modulates gene expression in astrocytes. Mol. Cell. Neurosci. 22, 202-209.
• Zawadzka M., Kaminska B., 2005. A novel mechanism of FK506 mediated neuroprotection: down-regulation of cytokine expression in glial cells. Glia 49, 36-51.